Medibank Pvt Ltd (FRA:MPV) Stock Price, Trades & News

Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.

Financial Strength

6/10

Name	Current	Vs Industry
Cash-To-Debt	1.65
Equity-to-Asset	0.55
Debt-to-Equity	0.12
Debt-to-EBITDA	0.35
Interest Coverage	41.26
Piotroski F-Score	5/9	0 1 2 3 4 5 6 7 8 9
Beneish M-Score	-2.11	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

5/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	6.4
	3-Year EBITDA Growth Rate	7.2
	3-Year EPS without NRI Growth Rate	8.4
	3-Year FCF Growth Rate	-30.2
	3-Year Book Growth Rate	6.3
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	6.55
	Future 3-5Y Total Revenue Growth Rate Estimate	5.31

Momentum Rank

5/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	54.6
	9-Day RSI	55.8
	14-Day RSI	56.55
	3-1 Month Momentum %	10.61
	6-1 Month Momentum %	8.15
	12-1 Month Momentum %	5.04

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	3.68
	Dividend Payout Ratio	1.07
	3-Year Dividend Growth Rate	9.8
	Forward Dividend Yield %	3.46
	5-Year Yield-on-Cost %	4.99
	Shareholder Yield %	3.66

Profitability Rank

7/10

	Name	Current	Vs Industry		Vs History
	Net Margin %	5.3
	EBITDA Margin %	9.07
	FCF Margin %	2.56
	OCF Margin %	3.39
	ROE %	19.69
	ROA %	10.55
	ROIC %	12.37
	3-Year ROIIC %	31.91
	Years of Profitability over Past 10-Year	10
	Moat Score	5
	Tariff Resilience Score	9

GF Value Rank

5/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	29.58
	Forward PE Ratio	18.98
	PE Ratio without NRI	29.58
	Shiller PE Ratio	26.57
	Price-to-Owner-Earnings	24.6
	PS Ratio	1.57
	PB Ratio	5.85
	Price-to-Tangible-Book	8.22
	Price-to-Free-Cash-Flow	60.61
	Price-to-Operating-Cash-Flow	46.02
	EV-to-EBIT	19.37
	EV-to-EBITDA	17.04
	EV-to-Revenue	1.55
	EV-to-Forward-Revenue	1.14
	EV-to-FCF	59.72
	Price-to-GF-Value	1.13
	Price-to-Projected-FCF	2.06
	Price-to-Median-PS-Value	1.28
	Price-to-Graham-Number	3.29
	Earnings Yield (Greenblatt) %	5.16
	FCF Yield %	1.65

GF Value™: €2.61

FRA:MPV

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with MPV. Try a 7-Day Free Trial to check it out.

Medibank Pvt Ltd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Medibank Pvt Ltd Stock Events

Financials Calendars

Event	Date	Price (€)
General meeting for 2026	2026-11-19	In 143 days
Fourth quarter earnings conference call for 2026	2026-08-28 09:30	In 61 days
Annual report for 2026	2026-08-28	In 60 days
Fourth quarter earnings results for 2026	2026-08-28	In 60 days
AUD 0.083000 Cash Dividend	2026-02-26	2.66 (+0.76%)
Second quarter earnings conference call for 2026	2026-02-19 09:30	2.84 (+0.00%)
Second quarter earnings results for 2026	2026-02-18	2.66 (+0.00%)
General meeting for 2025	2025-11-19	2.66 (+0.00%)
AUD 0.102000 Cash Dividend	2025-09-10	2.74 (+0.00%)
Fourth quarter earnings conference call for 2025	2025-08-28 09:30	2.84 (+0.00%)

Show

Entries

Press Release

	Subject	Date
No Press Release

Articles on Medibank Pvt Ltd

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.